ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, announces the details of its upcoming TECHDAY event on Friday, ...

ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies is set to host TECHDAY, showcasing its cutting-edge ...

Media reports state that Boeing Co. (BA) is considering selling its space business as losses mount at the commercial aircraft ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) found its stock slumping Monday. The AI-driven biotherapeutic research and technology company announces its significant contribution to a groundbreaking ...

Highlights,ImmunoPrecise Antibodies,(NASDAQ:IPA),contributes to a significant study on mitochondrial dysfunction.,The ...

ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), an AI-driven biotherapeutic research and technology ...

ImmunoPrecise Antibodies (IPA) has released an update. ImmunoPrecise Antibodies has made a significant stride in anti-aging research by ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The volatility ratio for the week is 12.02%, and the volatility levels for the last 30 days are 10.45% for ImmunoPrecise Antibodies Ltd The simple moving average for the past 20 days is -8.25% for IPA ...

Roivant's high valuation stems from its strong cash position, promising drug pipeline, Techbio assets, and strategic partnerships, making it a compelling buy. Recent sales of Telavant and ...